Cargando…
Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study
BACKGROUND: We previously established a 53-gene prognostic signature for overall survival (OS) of gastric cancer patients. This retrospective multi-center study aimed to develop a clinically applicable gene expression detection assay and to investigate the prognostic value of this signature. METHODS...
Autores principales: | Zhu, Linghua, Wang, Haifeng, Jiang, Chengfei, Li, Wenhuan, Zhai, Shuting, Cai, Xiujun, Wang, Xianfa, Liao, Linghong, Tao, Feng, Jin, Dexi, Chen, Guofu, Xia, Yankai, Mao, Jian-Hua, Li, Bin, Wang, Pin, Hang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569189/ https://www.ncbi.nlm.nih.gov/pubmed/33069062 http://dx.doi.org/10.1016/j.ebiom.2020.103023 |
Ejemplares similares
-
Application of Overlap Gastroduodenostomy in Billroth I Anastomosis after Totally Laparoscopic Distal Gastrectomy for Gastric Cancer
por: Chen, Guojun, et al.
Publicado: (2022) -
Weight loss and metabolic benefits of bariatric surgery in China: A multicenter study
por: Feng, Wenhuan, et al.
Publicado: (2023) -
Single-cell sequencing analysis reveals gastric cancer microenvironment cells respond vastly different to oxidative stress
por: Yu, Weihua, et al.
Publicado: (2022) -
Prognostic Value of Enolase Gene Family in Colon Cancer
por: Pan, Xiaohang, et al.
Publicado: (2020) -
Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
por: Liu, Zhenyu, et al.
Publicado: (2020)